174 related articles for article (PubMed ID: 9400994)
1. Identification and characterization of R-ras3: a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution.
Kimmelman A; Tolkacheva T; Lorenzi MV; Osada M; Chan AM
Oncogene; 1997 Nov; 15(22):2675-85. PubMed ID: 9400994
[TBL] [Abstract][Full Text] [Related]
2. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
3. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins.
Movilla N; Crespo P; Bustelo XR
Oncogene; 1999 Oct; 18(43):5860-9. PubMed ID: 10557073
[TBL] [Abstract][Full Text] [Related]
5. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein.
Wolthuis RM; Bauer B; van 't Veer LJ; de Vries-Smits AM; Cool RH; Spaargaren M; Wittinghofer A; Burgering BM; Bos JL
Oncogene; 1996 Jul; 13(2):353-62. PubMed ID: 8710374
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes.
Saez R; Chan AM; Miki T; Aaronson SA
Oncogene; 1994 Oct; 9(10):2977-82. PubMed ID: 8084601
[TBL] [Abstract][Full Text] [Related]
7. Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
Zohar M; Teramoto H; Katz BZ; Yamada KM; Gutkind JS
Oncogene; 1998 Aug; 17(8):991-8. PubMed ID: 9747878
[TBL] [Abstract][Full Text] [Related]
8. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells.
Kimmelman AC; Osada M; Chan AM
Oncogene; 2000 Apr; 19(16):2014-22. PubMed ID: 10803462
[TBL] [Abstract][Full Text] [Related]
9. TC21 and Ras share indistinguishable transforming and differentiating activities.
Graham SM; Oldham SM; Martin CB; Drugan JK; Zohn IE; Campbell S; Der CJ
Oncogene; 1999 Mar; 18(12):2107-16. PubMed ID: 10321735
[TBL] [Abstract][Full Text] [Related]
10. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.
Rey I; Taylor-Harris P; van Erp H; Hall A
Oncogene; 1994 Mar; 9(3):685-92. PubMed ID: 8108110
[TBL] [Abstract][Full Text] [Related]
11. Distinct expression patterns and transforming properties of multiple isoforms of Ost, an exchange factor for RhoA and Cdc42.
Lorenzi MV; Castagnino P; Chen Q; Hori Y; Miki T
Oncogene; 1999 Aug; 18(33):4742-55. PubMed ID: 10467422
[TBL] [Abstract][Full Text] [Related]
12. A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line.
Huang Y; Saez R; Chao L; Santos E; Aaronson SA; Chan AM
Oncogene; 1995 Oct; 11(7):1255-60. PubMed ID: 7478545
[TBL] [Abstract][Full Text] [Related]
13. The TC21 oncoprotein interacts with the Ral guanosine nucleotide dissociation factor.
López-Barahona M; Bustelo XR; Barbacid M
Oncogene; 1996 Feb; 12(3):463-70. PubMed ID: 8637701
[TBL] [Abstract][Full Text] [Related]
14. R-Ras is regulated by activators and effectors distinct from those that control Ras function.
Huff SY; Quilliam LA; Cox AD; Der CJ
Oncogene; 1997 Jan; 14(2):133-43. PubMed ID: 9010215
[TBL] [Abstract][Full Text] [Related]
15. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells.
Cox AD; Brtva TR; Lowe DG; Der CJ
Oncogene; 1994 Nov; 9(11):3281-8. PubMed ID: 7936652
[TBL] [Abstract][Full Text] [Related]
16. Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.
Carboni JM; Yan N; Cox AD; Bustelo X; Graham SM; Lynch MJ; Weinmann R; Seizinger BR; Der CJ; Barbacid M
Oncogene; 1995 May; 10(10):1905-13. PubMed ID: 7761092
[TBL] [Abstract][Full Text] [Related]
17. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
18. A novel Rho GTPase-activating-protein interacts with Gem, a member of the Ras superfamily of GTPases.
Aresta S; de Tand-Heim MF; Béranger F; de Gunzburg J
Biochem J; 2002 Oct; 367(Pt 1):57-65. PubMed ID: 12093360
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
[TBL] [Abstract][Full Text] [Related]
20. Identification of Rgl3 as a potential binding partner for Rap-family small G-proteins and profilin II.
Xu J; Shi S; Matsumoto N; Noda M; Kitayama H
Cell Signal; 2007 Jul; 19(7):1575-82. PubMed ID: 17382517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
